RSS Feed from EMA on New Human Medicines
- Human medicines European public assessment report (EPAR): Cenrifki, tolebrutinib, Status: Opinion
- Human medicines European public assessment report (EPAR): Rexatilux, ranibizumab, Status: Opinion
- Human medicines European public assessment report (EPAR): Redemplo, plozasiran, Status: Opinion
- Human medicines European public assessment report (EPAR): Palbociclib Viatris, palbociclib, Status: Opinion
- Human medicines European public assessment report (EPAR): Itvisma, onasemnogene abeparvovec, Status: Opinion
- Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes, in-vitro expanded, Status: Application withdrawn
- EMA actively monitoring cruise ship Hantavirus outbreak
- EMA business hours over Ascension Day holidays, 14 and 15 May
- EMA welcomes political agreement on Critical Medicines Act
- Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 May 2026
- EU recommendations for 2026/2027 seasonal flu vaccine composition
MedWatch Safety Alert RSS Feed
- Sun Pharmaceutical Industries, Inc. (Sun Pharma) Initiates Voluntary U.S. Nationwide Recall of DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL Due To Potential Presence of Glass Particles
- Convenience Kit Recall: AVID Medical Removes Convenience Kits Containing Namic RA Syringes
- Pharmacal Issues Nationwide Recall of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream Due to Microbial Contamination
- Convenience Kit Recall: Aligned Medical Solutions Removes Convenience Kits Containing Namic RA Syringes
- Convenience Kit Recall: Medical Action Industries Removes Convenience Kits Containing Namic RA Syringes
- Pacemaker Correction: Boston Scientific Issues Correction for ACCOLADE Pacemakers and CRT-Ps
- Convenience Kit Recall: American Contract Systems Removes Convenience Kits Containing Namic RA Syringes
- Accolade Pacemaker Devices by Boston Scientific and Potential Need for Early Device Replacement - FDA Safety Communication
- Disruptions in Availability of Neurosurgical Patties, Sponges, and Strips - Letter to Health Care Providers
- Sizing Catheter Recall: Cook Medical Removes Various Centimeter Sizing Catheters
FDA Stay Informed on New Drugs
- Withdrawn | Infectious Disease Accelerated Approvals
- Accelerated Approval Program
- Ongoing | Non-malignant Hematological, Neurological, and Other Disorder Indications Accelerated Approvals
- Recently Issued Guidance Documents
- Generic Drug User Fee Amendments
- What's New Related to Drugs
- FDA approves first interchangeable biosimilars to Simponi and Simponi Aria (golimumab) to treat rheumatoid arthritis and ulcerative colitis
- Pain and Arthritis Products Containing Hidden Ingredients
- Sâm Xương Khớp Ông Tiên may be harmful due to hidden drug ingredients
- Notable Approvals | Drugs